Double-Blind, Placebo-Controlled Comparison of the Efficacy of Sertraline as Treatment for a Major Depressive Episode in Patients With Remitted Schizophrenia-Reference-Cited by-同舟云学术

Double-Blind, Placebo-Controlled Comparison of the Efficacy of Sertraline as Treatment for a Major Depressive Episode in Patients With Remitted Schizophrenia

Published:2002-02 Issue:1 Volume:22 Page:20-25
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:Journal of Clinical Psychopharmacology

Author:

Addington Donald,Addington Jean,Patten Scott,Remington Gary,Moamai Javad,Labelle Alain,Beauclair Linda

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference28 articles.

1. Diagnosis of Secondary Depression in Schizophrenia: Implications for DSM-IV

2. CONDITIONS PREDISPOSING TO SUICIDE

3. Suicide in Chronic Schizophrenia

4. Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*

5. Antidepressant Usage in Schizophrenia

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short-term, but not long-term, beneficial effects of concomitant benzodiazepine use on clinical course in patients with schizophrenia;International Clinical Psychopharmacology;2022-01-17

2. Smoking blunts sertraline response in depression: A prospective observational cohort study;Medical Journal Armed Forces India;2022-01

3. Diagnosis and Treatment of Depression in Patients with Schizophrenia;Consortium Psychiatricum;2020-12-03

4. Adjunctive Medications;Psychotic Disorders;2019-12-05

5. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis;Schizophrenia Research;2018-03